Heart Rhythm

Hearts should have normal rhythm to their beats, but when these beats are out of synch, it causes inefficient pumping of blood. Irregular heart arrhythmias occur when the electrical signals that coordinate the heart's beats do not work properly. This can cause beats that are too fast (tachycardia), or too slow (bradycardia). Tachycardias include atrial fibrillation (AFib), supraventricular tachycardia, ventricular fibrillation, and ventricular tachycardia (VT). Bradycardias include sick sinus syndrome and conduction block. Electrophysiology arrhythmia treatments include medications, life style changes, and the EP lab interventions of catheter ablation, and implantable pacemakers or defibrillators.

Thumbnail

Slow heart rates reported in COVID-19 patients treated with lopinavir, ritonavir

Treating critically ill COVID-19 patients with a combination of lopinavir (LPV) and ritonavir (RTV) is associated with a significant risk of bradycardia, according to new research out of France.

Abbott’s line of next-generation heart rhythm devices gains FDA approval

The devices offer numerous new features, including an improved battery, MRI compatibility and Bluetooth connectivity.

Thumbnail

Cloud-based imaging spinoff inHeart raises $4.2M for AI-based heart arrhythmia solution

It’s cloud software turns preoperative medical images into a 3D “digital twin” of the patient’s heart enabling providers to plan procedures and navigate instruments during surgery.

Thumbnail

Study shows COVID-19 can infect heart cells—and do serious damage in the process

COVID-19 has the potential to infect cardiac cells, causing changes in their ability to function after just 72 hours. 

Thumbnail

Cardiologists shed new light on COVID-19 and cardiac arrhythmias

A higher rate of cardiac arrhythmias has been observed in hospitalized COVID-19 patients, but new research suggests there’s more behind that trend than the virus itself.

Thumbnail

Azithromycin associated with greater risk of cardiovascular death, but not sudden cardiac death

Outpatient prescriptions for azithromycin are associated with an increased risk of cardiovascular mortality, according to new research published in JAMA Network Open.

Thumbnail

Dexamethasone improves outcomes for critically ill COVID-19 patients

Why dexamethasone could be a legitimate game-changer in the fight against COVID-19—and an update on the FDA and hydroxychloroquine.

Thumbnail

Cardiologist makes history, performs first cardioneural ablation in US

A cardiologist at the University of Chicago Medicine has performed the first cardioneural ablation in U.S. history, using it to “rewire” the heart of a patient suffering from vasovagal syncope.